revealed that the ratio of CD8+ effector cells to Tregs in the SCLC-N subtype is significantly lower than in SCLC-A, correlating with a poorer prognosis for patients with SCLC-N (30). The gene discussed is CD8A; the disease is small cell lung carcinoma.